Seattle, WA
Summary
This business focuses on harnessing the power of the adaptive immune system to develop innovative diagnostic and therapeutic solutions. It offers a range of services including immune medicine platform development, clinical testing, and drug discovery, specifically targeting minimal residual disease (MRD) assessment and T-cell receptor therapeutics. The company aims to transform disease detection and treatment through advanced immune receptor data and technology.
Based on content on adaptivebiotech.com
cofactorgenomics.com
St. Louis, Missouri
Biotechnology and healthcare diagnostics.